Journal
/
Neuroscience
/
Demielinizzazione sperimentale e rimielinizzazione di Murine midollo spinale da iniezione focale Lysolecithin
JoVE Journal
Neuroscience
This content is Free Access.
JoVE Journal Neuroscience
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Please note that all translations are automatically generated. Click here for the English version.

Demielinizzazione sperimentale e rimielinizzazione di Murine midollo spinale da iniezione focale Lysolecithin

italiano

Automatically Generated

26,503 Views

•

08:57 min

•

March 26, 2015

DOI:

10.3791/52679-v

DOI:
10.3791/52679-v

•

08:57 min
March 26, 2015

•

19 Views
, ,
1Department of Clinical Neurosciences,Hotchkiss Brain Institute at University of Calgary, 2Department of Oncology,Hotchkiss Brain Institute at University of Calgary

Summary

Automatically generated

Demyelinating diseases can be modeled in animals by focal application of lysolecithin into the CNS. A single injection of lysolecithin into mouse spinal cord produces a lesion that spontaneously repairs over time. The goal is to study factors involved in de- and remyelination, and to test agents for enhancing repair.

Explore More Videos

Experimental DemyelinationRemyelinationMurine Spinal CordLysolecithinMultiple SclerosisOligodendrocyte Precursor CellsAnimal ModelCentral Nervous SystemSpinal Cord White MatterRemyelination-promoting Therapeutics

Read Article

Cite this Article

Keough, M. B., Jensen, S. K., Yong, V. W. Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin. J. Vis. Exp. (97), e52679, doi:10.3791/52679 (2015).

Download .ris file

Copy

Share Video

.

Copy